GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 50 filers reported holding GT BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,109 | +122.9% | 8,750 | +188.5% | 0.00% | – |
| Q2 2023 | $946 | -77.9% | 3,033 | -61.1% | 0.00% | – |
| Q1 2023 | $4,286 | +36.7% | 7,793 | +121.2% | 0.00% | – |
| Q4 2022 | $3,135 | -37.3% | 3,523 | +11.1% | 0.00% | – |
| Q3 2022 | $5,000 | -44.4% | 3,170 | +1.7% | 0.00% | – |
| Q2 2022 | $9,000 | -30.8% | 3,116 | -29.2% | 0.00% | – |
| Q1 2022 | $13,000 | -61.8% | 4,401 | -61.5% | 0.00% | – |
| Q4 2021 | $34,000 | +6.2% | 11,444 | +140.5% | 0.00% | – |
| Q3 2021 | $32,000 | -33.3% | 4,758 | +53.3% | 0.00% | – |
| Q2 2021 | $48,000 | +77.8% | 3,103 | -20.8% | 0.00% | – |
| Q1 2021 | $27,000 | – | 3,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crumly & Associates Inc. | 32,163 | $93,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 20,075 | $58,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,260 | $81,000 | 0.00% |
| Sigma Planning Corp | 21,400 | $62,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 30,000 | $86,000 | 0.00% |
| Gordian Capital Singapore Pte Ltd | 35,000 | $3,000 | 0.00% |
| Welch Group, LLC | 10,000 | $29,000 | 0.00% |
| Renaissance Technologies | 186,300 | $537,000 | 0.00% |
| BRIGHTON JONES LLC | 11,012 | $32,000 | 0.00% |
| Capital Advisors, Ltd. LLC | 24 | $0 | 0.00% |